Key result
The AAIsafeR2 pacing mode was safe with no related adverse events and maintained average ventricular pacing at 0.2% in patients with non-sustained switches to DDD mode.
Why the study?
Does the AAIsafeR2 pacing mode safely minimize unnecessary ventricular pacing in patients with dual chamber pacemakers?
Observational (n=123)
Does the AAIsafeR2 pacing mode safely minimize unnecessary ventricular pacing in patients with dual chamber pacemakers?
The AAIsafeR2 pacing mode appears safe and effective at maintaining ventricular pacing below 1% in patients with infrequent ventricular slowing or pauses.
Answers are grounded in this paper and cite their sources.
May support AAIsafeR2 to limit ventricular pacing in select patients; hypothesis-generating and should not yet change practice.
AIMS: To examine the performance of AAIsafeR2, a new pacing mode to minimize the cumulative proportion of ventricular pacing in patients who do not need regular ventricular support. METHODS AND RESULTS: The safety of AAIsafeR2 was examined in 123 recipients (73 +/- 12 years old, 51% men) of dual chamber pacemakers implanted for sinus node dysfunction, paroxysmal AV block or the bradycardia-tachycardia syndrome. Data were collected from pacemaker diagnostics, and the first 43 patients underwent 24-h Holter recordings before being discharged from the hospital with AAIsafeR2 activated. No adverse event related to AAIsafeR2 was observed. All ventricular pauses detected on Holter tapes triggered immediate back-up ventricular pacing. Appropriate switches to DDD occurred in 97 of 123 patients. In 69 of 123 devices (56%) switches to DDD were non-sustained, and the average % ventricular pacing in this group was 0.2+/-0.5%. CONCLUSION: AAIsafeR2 mode seems to be safe and reliable in patients with infrequent slowing or pauses in ventricular activity, while maintaining ventricular pacing below 1%.
No takes yet. Share an insight, caveat, or question.
Fröhlig et al. (2006) conducted an observational in Sinus node dysfunction, paroxysmal AV block or bradycardia-tachycardia syndrome (n=123). AAIsafeR2 pacing mode was evaluated on Safety and cumulative proportion of ventricular pacing. The AAIsafeR2 pacing mode was safe with no related adverse events and maintained average ventricular pacing at 0.2% in patients with non-sustained switches to DDD mode.
Synapse has enriched 10 related papers. Consider them for comparative context: